Pathogenesis and treatment of premenstrual dysphoric disorder: research progress
CSTR:
Author:
Affiliation:

Clc Number:

R749.42

Fund Project:

Supported by Key Discipline Construction Program of Shanghai Pudong New Area Health and Family Planning Commission (PWZzk2017-20).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Premenstrual dysphoric disorder (PMDD) is diagnosed as a type of mood disorder in the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5). In addition to depressive symptoms, PMDD can be accompanied by somatic symptoms and is characterized by cyclicity (premenstrual). The etiology and pathogenesis of PMDD are not clear, probably involving the fluctuation of estrogen, the weakened role of neurosteroids hormones, immune activation and inflammatory response, the abnormal functional activities of some brain areas (such as amygdala, prefrontal cortex), psychosocial factors, etc. There is no radical treatment for PMDD due to the unknown pathogenesis. Treatments including drugs (such as antidepressants, oral contraceptives), psychotherapy, and complementary medicines (such as traditional Chinese medicine, acupuncture) are used to relieve patients' symptoms.

    Reference
    Related
    Cited by
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 20,2020
  • Revised:August 28,2021
  • Adopted:
  • Online: December 18,2021
  • Published:
Article QR Code